Fig. 3From: Estimating the returns to United Kingdom publicly funded musculoskeletal disease research in terms of net value of improved health outcomesReal term expenditure, 2013 prices, on MSD research 1978 to 1997 (shaded area for 1978 to 1997)Back to article page